logo

Aquestive Therapeutics Inc. (AQST)



Trade AQST now with
  Date
  Headline
8/20/2020 7:35:38 AM Aquestive Therapeutics Initiates Phase 1 Pharmacokinetic Trial Of AQST-108 For Allergic Reactions Incl Anaphylaxis
6/29/2020 7:25:07 AM Aquestive Therapeutics Submits IND For Pharmacokinetic Clinical Trials Of AQST-108 For Anaphylaxis Treatment
1/12/2020 8:03:08 PM Aquestive Therapeutics Gets FDA Response To Citizen’s Petition
1/10/2020 6:36:07 AM Aquestive Therapeutics Sees Q4 Preliminary Total Revenues To Be $16 Mln; Issues 2020 Revenues View Of $35 Mln-$45 Mln
12/12/2019 10:45:01 PM Aquestive Therapeutics Prices Public Offering Of 7 Mln Shares At $5.00/shr
11/25/2019 8:10:35 AM Aquestive: Exservan Oral Film Receives Early-action Approval From FDA
11/25/2019 6:14:41 AM AQST Soars On FDA Approval
9/30/2019 7:14:17 AM Aquestive Therapeutics Completes Phase 1 Study In Healthy Subjects For AQST-108
6/4/2019 8:07:20 AM Aquestive Therapeutics Completes Enrollment In Libervant Crossover Study
5/8/2019 7:14:34 AM Aquestive Therapeutics Posts Q1 Net Loss Of $14.7 Mln Or $0.59 Per Share
4/16/2019 8:05:51 AM Aquestive Therapeutics Announces FDA Acceptance Of New Drug Application For Riluzole Oral Film For ALS
3/18/2019 6:31:52 AM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) FY19 Rev. Estimate To 44.5 M From 57.4 M
3/18/2019 6:31:35 AM Wedbush Is Cutting Aquestive Therapeutics Inc. (AQST) Q4 19 Rev. Estimate To 10.6 M From 11.8 M
3/18/2019 6:31:18 AM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) Q3 19 Rev. Estimate To 10.2 M From 19.3 M